Loading candles…
Ami Organics Limited, formerly known as Acutaas Chemicals Limited, is a manufacturer focused on specialty chemicals, including advanced pharmaceutical intermediates, active pharmaceutical ingredients (APIs) for new chemical entities, and materials used in agrochemicals and fine chemicals. The company operates as a research and development-driven entity serving multiple industries such as specialty chemicals, pharmaceuticals, semiconductors, energy storage, agrochemicals, and fine chemicals. It supplies manufacturing solutions and high-performance materials to customers in over 55 countries. Ami Organics' notable work includes manufacturing advanced pharmaceutical intermediates and APIs for new chemical entities and providing solutions for pharmaceutical, semiconductor, and energy storage sectors. There are no details provided on the company's incorporation year, founders, key management, subsidiaries, or stock exchange listings.
This page is a live market overview for ACUTAAS CHEMICALS LIMITED (ACUTAAS) on the NSE. As a listed security, ACUTAAS CHEMICALS LIMITED is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for ACUTAAS before placing trades on tick2trade.
As of the latest feed, ACUTAAS last traded at ₹3,297.9 on NSE, up ₹37.3 (1.14%) from the previous close of ₹3,260.6. Today's session range is ₹3,239.9 – ₹3,328, against a 52-week band of ₹1,261.2 – ₹3,740. Traded volume today stands at 1.88L shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for ACUTAAS in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether ACUTAAS is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for ACUTAAS CHEMICALS LIMITED before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in ACUTAAS. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated ACUTAAS option chain page linked from this overview.
| Type | Details | Date |
|---|---|---|
| Results - FY26 | To consider and approve the financial results for the period ended Jun 30, 2026 | 24 Jul 2026 |
| Results - FY26 | To consider and approve the financial results for the period ended March 31, 2026 and dividend | 30 Apr 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended December 31, 2025 | 28 Jan 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended Jun 30, 2025 | 30 Jul 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended March 31, 2025, dividend and other business matters | 2 May 2025 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.